The hypoxic core: A possible answer to the cancer paradox

Biochemical and Biophysical Research Communications

Volumn 299, Issue 4, 2002, Pages 676-680

  Guppy, Michael ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Angiogenesis; Cancer; FDG; Glycolysis; HIF; Hypoxia; PET; pO2; Tumour; VEGF

Indexed keywords

PROTEIN; PROTEIN HIF 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL SURVIVAL; GLYCOLYSIS; HUMAN; HYPOXIA; NONHUMAN; OXYGEN TENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; UPREGULATION;

CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036910635     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02710-9     Document Type: Article

References (38)

1. P. Vaupel, O. Thews, D.K. Kelleher, M. Hoeckel, Current status of knowledge and critical issues in tumour oxygenation. Results from 25 years research in tumour pathophysiology, Adv. Exp. Med. Biol. 454 (1998) 591-602.
2. O. Warburg, Ist die aerobe glykolyse spezifisch fuer die tumoren?, Biochem. Z. 204 (1929) 482-483.
3. O. Warburg, On the origin of cancer cells, Science 123 (1956) 309-314.
4. M. Guppy, S. Kong, X. Niu, S. Busfield, S.P. Klinken, Method for measuring a comprehensive energy budget in a proliferating cell system over multiple cell cycles, J. Cell. Physiol. 170 (1997) 1-7.
5. K.F. Czerwenka, M. Manavi, J. Hosmann, J. D, I. Kerstin, D. Pischinger, W.B. Battistutti, M. Behnam, E. Kubista, Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue, Cancer Detect. Prev. 25 (2001) 268-279.
6. G.A. Chen, T.G. Gharib, C.C. Huang, D.G. Thomas, K.A. Shedden, J.M.G. Taylor, S.L.R. Kardia, D.E. Misek, T.J. Giordano, M.D. Iannettoni, M.B. Orringer, S.M. Hanash, D.G. Beer, Proteomic analysis of lung adenocarcinoma: Identification of a highly expressed set of proteins in tumors, Clin. Cancer Res. 8 (2002) 2298-2305.
7. A.C.O. Vertegaal, H.B. Kuiperij, T. van Laar, V. Scharnhorst, A.J. van der Eb, A. Zantema, cDNA micro array identification of a gene differentially expressed in adenovirus type 5- versus type 12-transformed cells, FEBS 487 (2000) 151-155.
8. J.A. Mares-Perlman, E. Shrago, Energy substrate utilization in freshly isolated Morris hepatoma 7777 cells, Cancer Res. 48 (1988) 602-608.
9. M. Guppy, P. Leedman, X. Zu, V. Russel, Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells, Biochem. J. 364 (2002) 309-315.
10. A. Franchi, P. Silvestre, J. Pouyssegur, A genetic approach to the role of energy metabolism in the growth of tumor cells: tumor-igenicity of fibroblast mutants deficient either in glycolysis or in respiration, Int. J. Cancer 27 (1981) 819-827.
11. E.K.J. Pauwels, E.J.C. Sturm, E. Bombardieri, F.J. Cleton, M.P.M. Stokkel, Positron-emission tomography with [18F]fluorodeoxyglucose. Part 1. Biochemical uptake mechanism and its implication for clinical studies, J. Cancer Res. Clin. Oncol. 126 (2000) 549-559.
12. D.A. Mankoff, J.R. Bellon, Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond, Semin. Radiat. Oncol. 11 (2001) 16-27.
13. K. Murthy, M. Aznar, C.J. Thompson, A. Loutfi, R. Lisbona, J.H. Gagnon, Results of preliminary clinical trials of the positron emission mammography system PEM-I: A dedicated breast imaging system producing glucose metabolic images using FDG, J. Nucl. Med. 41 (2000) 1851-1858.
14. N. Avril, M. Menzel, J. Dose, M. Schelling, W. Weber, F. Janicke, W. Nathrath, M. Schwaiger, Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis, J. Nucl. Med. 42 (2001) 9-16.
15. R. Bos, J.J.M. van der Hoeven, E. van der Wall, P. van der Groep, P.J. van Diest, E.F.I. Comans, U. Joshi, G.L. Semenza, O.S. Hoekstra, A.A. Lammertsma, C.F.M. Molthoff, Biologic correlates of 18 fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography, J. Clin. Oncol. 20 (2002) 379-387.
16. P. Burgman, J.A. O'Donoghue, J.L. Humm, C.C. Ling, Hypoxia-induced increase in FDG uptake in MCF7 cells, J. Nucl Med. 42 (2001) 170-175.
17. J.N. Thupari, M.L. Pinn, F.P. Kuhajda, Fatty acid synthase inhibition in human breast cancer cells leads to malonyl CoA-induced inhibition of fatty acid oxidation and cytotoxicity, Biochem. Biophys. Res. Commun. 285 (2001) 217-223.
18. S. Chang, S. Lee, C. Lee, J.I. Kim, Y. Kim, Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder, Urology 55 (2000) 448-452.
19. M. Younes, D. Juarez, L.V. Lechago, S.P. Lerner, Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival, Anticancer Res. 21 (2001) 575-578.
20. P.R. Wachsberger, E.L. Gressen, A. Bhala, S.B. Bobyock, C. Storck, R.A. Coss, D. Berd, D.B. Leeper, Variability in glucose transporter-1 levels and hexokinase activity in human melanoma, Melanoma Res. 12 (2002) 35-43.
21. E.M. Marom, T.A. Aloia, M.-B. Moore, M. Hara, J.E. Herndon, D.H. Harpole Jr., P.C. Goodman, E.F. Patz Jr., Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer, Lung Cancer 33 (2001) 99-107.
22. J.M. Brown, The hypoxic cell: A target for selective cancer therapy, Cancer Res. 59 (1999) 5863-5870.
23. P. Vaupel, M. Hockel, Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance, Int. J. Oncol. 17 (2000) 869-879.
24. 2 homeostasis by hypoxia-inducible factor 1, Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578.
25. G.L. Semenza, Hypoxia, clonal selection, and the role of HIF-1 in tumor progression, Crit. Rev. Biochem. Mol. Biol. 35 (2000) 71-103.
26. G.L. Semenza, HIF-1 and tumor progression: Pathophysiology and therapeutics, Trends Mol. Med. 8 (2002) S62-S67.
27. A. Giatromanolaki, A.L. Harris, Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer, Anticancer Res. 21 (2001) 4317-4324.
28. H. Jiang, R. Guo, J.A. Powell-Coffman, The Caenorhabditis elegans HIF-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia, Proc. Natl. Acad. Sci. USA 98 (2001) 7916-7921.
29. 2, and the 3 PHDs: How animal cells signal hypoxia to the nucleus, Cell 107 (2001) 1-3.
30. U.R. Jewell, I. Kvietikova, A. Scheid, C. Bauer, R.H. Wenger, M. Gassmann, Induction of HIF-1α in response to hypoxia is instantaneous, FASEB J. 15 (2001) 1312-1314.
31. N. Masson, C. Willam, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, Independent function of two destruction domains in hyoxia-inducible factor-α chains activated by prolyl hydroxylation, EMBO J. 20 (2001) 5197-5206.
32. D.M. Stroka, T. Burkhardt, I. Desbaillets, R.H. Wenger, D.A.H. Neil, C. Bauer, M. Gassmann, D. Candinas, HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia, FASEB J. 15 (2001) 2445-2453.
33. D.P. Stiehl, W. Jelkmann, R.H. Wenger, T. Hellwig-Burgel, Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway, FEBS Lett. 512 (2002) 157-162.
34. C.H. Kim, Y.S. Cho, Y.S. Chun, J.W. Park, M.S. Kim, Early expression of myocardial HIF-1α in response to mechanical stresses. Regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway, Circ. Res. 90 (2002) E25-E33.
35. E.K. Rofstad, Microenvironment-induced cancer metastasis, Int. J. Radiat. Biol. 76 (2000) 589-605.
36. H. Lu, R.A. Forbes, A. Verma, Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis, J. Biol. Chem. 277 (2002) 23111-23115.
37. M. Wartenberg, F. Donmez, F.C. Ling, H. Acker, J. Hescheler, H. Sauer, Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells, FASEB J. 15 (2001) 995-1005.
38. 2 tension, Am. J. Physiol. 271 (1996) C1172-C1180.